Biomira Inc. delays start of next cancer vaccine trial, perhaps until 2006

EDMONTON (CP) - Biomira Inc. says a "stability issue" has caused a delay in starting a Phase 3 study for its vaccine treatment of non-small-cell lung cancer....More